| abstract |
Disclosed is the use of a composition comprising lacto-N-neotetraose in the manufacture of a medicament for reducing inflammation in an infant, toddler, or child, wherein the lacto-N-neotetraose is present in the composition in a concentration of 0.001 mg/mL to 0.2 mg/mL. Also disclosed is the use of a composition comprising lacto-N-neotetraose in the manufacture of a medicament for treating a respiratory virus induced infection by inhibiting the growth of respiratory viruses in an infant, toddler, or child, wherein the lacto-N-neotetraose is present in the composition in a concentration of 0.001 mg/mL to 0.2 mg/mL. |